Baseline characteristics of the patients*
Variable | No of patients (n = 29) | |
---|---|---|
CDAI, Crohn’s disease activity index; 6-MP, 6-mercaptopurine. | ||
Sex (M/F) | 13/16 (44.8% M) | |
Mean age (y) | 34.0 (10.8) | |
Smoking status (yes/total) | 9/29 (31%) | |
Initial CDAI | 296.7 (46.9) | |
Median duration of disease (y) | 4 (1.5–8) | |
Site of disease | ||
Small bowel only | 10/29 (34.5%) | |
Colon only | 5/29 (17.2%) | |
Small bowel and colon | 14/29 (48.3%) | |
Ileal resection | 5/29 (17.2%) | |
Medications at entry | ||
No medications | 5/29 (17.2%) | |
Mesalamine | 10/29 (34.5%) | |
Corticosteroid | 3/29 (10.3%) | |
Azathioprine | 3/29 (10.3%) | |
Mesalamine+corticosteroid | 1/29 (3.4%) | |
Mesalamine+azathioprine/6-MP | 1/29 (3.4%) | |
Corticosteroid+azathioprine/6-MP | 3/29 (10.3%) | |
Mesalamine+corticosteroid+azathioprine/6-MP | 3/29 (10.3%) |